Blog

Australian SUPER-NEXT study to measure the clinical value of the ‘whole genome’ approach to CUP receives $5M funding

SUPER is an Australian  CUP trial that has been running for some time and as part of it  SUPER-NEXT, led by Richard Tothill, will evaluate WGS when used to help resolve a tumour type diagnosis and improve therapeutic decision making in CUP. 

CUP at Virtual ASCO

The recent ASCO Virtual included a session on CUP under the heading ‘Redefining Cancer of Unknown Primary: Is Genomics the Answer?’ The Discussants were Tony Greco (USA) and Karim Fizazi (Fr) and papers were from Australia, USA, Japan, and China. Further details and the abstracts (which can been seen without logging into an ASCO account) are shown here.